🍽️ flubendazol,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Anthelmintic Activity: Flubendazole works by interfering with the metabolism of parasitic worms, leading to their immobilization and death. It is effective against a broad spectrum of helminths, including nematodes (roundworms), cestodes (tapeworms), and trematodes (flukes).

  2. Treatment of Intestinal Worm Infections: Flubendazole is commonly used to treat intestinal worm infections, including infections caused by roundworms (such as Ascaris lumbricoides), whipworms (Trichuris trichiura), and hookworms (Ancylostoma duodenale, Necator americanus). It may also be effective against certain types of tapeworm infections.

  3. Eradication of Tissue Worms: Flubendazole may also be used to treat tissue-invasive helminth infections caused by parasites such as Strongyloides stercoralis and Trichinella spiralis. These parasites can infect various tissues and organs in the body, leading to potentially severe manifestations.

  4. Broad-Spectrum Action: Flubendazole's broad spectrum of activity makes it a versatile treatment option for various helminthic infections, especially in regions where multiple parasitic worm species are endemic.

  5. Route of Administration: Flubendazole is typically administered orally in the form of tablets or suspensions. The dosage and duration of treatment may vary depending on the type and severity of the parasitic infection, as well as the patient's age and weight.

  6. Adverse Effects: Common side effects of flubendazole may include gastrointestinal symptoms such as nausea, vomiting, abdominal pain, and diarrhea. These side effects are usually mild and transient. Rare but serious adverse effects may include allergic reactions, liver toxicity, and neurological symptoms.

  7. Contraindications and Precautions: Flubendazole should be used with caution in individuals with liver disease or a history of hypersensitivity reactions to anthelmintic medications. It may not be suitable for use during pregnancy or lactation, and its safety in pediatric populations has not been well established.

  8. Drug Interactions: Flubendazole may interact with certain medications, including drugs that induce or inhibit liver enzymes involved in its metabolism. It is important to inform healthcare providers about all medications, supplements, and herbal products being taken to avoid potential drug interactions.

  9. Monitoring and Follow-Up: Patients receiving treatment with flubendazole should be monitored for the resolution of symptoms and the eradication of parasitic infections. Follow-up testing, such as stool examinations, may be recommended to confirm the effectiveness of treatment and ensure complete parasite clearance.

  10. Public Health Impact: Flubendazole plays a crucial role in the control and prevention of parasitic worm infections, particularly in resource-limited settings where these infections are endemic. Mass drug administration programs may be implemented to reduce the burden of helminthic diseases in affected populations.


Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of flubendazol,(prescription) On Probiotics

Rank Probiotic Impact

Bacteria Impacted by flubendazol,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.


Taxonomy Rank Effect Citations Notation
Bacteroides genus Decreases 👪 Source Study
unclassified Robinsoniella no rank Decreases ⚗️ Source Study
unclassified Fusobacterium no rank Decreases ⚗️ Source Study
unclassified Negativicoccus no rank Decreases ⚗️ Source Study
Eggerthellales order Decreases ⚗️ Source Study
Anaerofustis stercorihominis species Decreases ⚗️ Source Study
Asaccharospora irregularis species Decreases ⚗️ Source Study
Negativicoccus sp. S5-A15 species Decreases ⚗️ Source Study
Paraprevotella clara species Decreases ⚗️ Source Study
Slackia sp. NATTS species Decreases ⚗️ Source Study
Pseudoflavonifractor capillosus species Decreases ⚗️ Source Study
[Collinsella] massiliensis species Decreases ⚗️ Source Study
Parvibacter caecicola species Decreases ⚗️ Source Study
Bacteroides thetaiotaomicron species Decreases 📓 Source Study
Bacteroides uniformis species Decreases 📓 Source Study Infectious bacteria
Bacteroides xylanisolvens species Decreases 📓 Source Study
Coriobacterineae suborder Decreases ⚗️ Source Study
Chlamydiae/Verrucomicrobia group superphylum Decreases ⚗️ Source Study

Impact of flubendazol,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
ADHD 0.1 0.1
Allergic Rhinitis (Hay Fever) 0 0
Allergy to milk products 0 0
Alzheimer's disease 0 0 0
Ankylosing spondylitis 0 0
Anorexia Nervosa 0 0
Antiphospholipid syndrome (APS) 0.1 0.1
Asthma 0 0
Atrial fibrillation 0 0 0
Autism 0 0 0
Bipolar Disorder 0 0
Brain Trauma 0 0
Carcinoma 0 0 0
Celiac Disease 0 0 0
Cerebral Palsy 0 0
Chronic Fatigue Syndrome 0.2 0 0
Chronic Kidney Disease 0 0
Chronic Lyme 0 0
Colorectal Cancer 0 0
Constipation 0 0
COVID-19 0.1 0.1 0
Crohn's Disease 0.1 0 0
cystic fibrosis 0 0
Depression 0.4 0 0
Endometriosis 0 0
Epilepsy 0 0 0
Fibromyalgia 0.1 -0.1
Functional constipation / chronic idiopathic constipation 0 0 0
Generalized anxiety disorder 0 0
Graves' disease 0 0
Halitosis 0 0
Hashimoto's thyroiditis 0 0 0
Histamine Issues 0 0
hyperglycemia 0 0
hypertension (High Blood Pressure 0 0 0
Hypoxia 0 0
IgA nephropathy (IgAN) 0.1 -0.1
Inflammatory Bowel Disease 0 0 0
Insomnia 0 0 0
Intelligence 0.1 0.1
Intracranial aneurysms 0 0
Irritable Bowel Syndrome 0.1 0.1 0
Liver Cirrhosis 0 0 0
Long COVID 0.1 0.1 0
ME/CFS with IBS 0 0
ME/CFS without IBS 0.1 0 0
Metabolic Syndrome 0 0.1 0
Mood Disorders 0.4 0 0
Multiple Sclerosis 0 0
neuropathic pain 0 0
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0 0
Obesity 0 0 0
obsessive-compulsive disorder 0.1 0 0
Osteoarthritis 0 0
Osteoporosis 0 0 0
Polycystic ovary syndrome 0 0
primary biliary cholangitis 0.1 -0.1
Psoriasis 0 0
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 0 0 0
Schizophrenia 0.1 0.1
Sjögren syndrome 0.1 -0.1
Sleep Apnea 0 0
Stress / posttraumatic stress disorder 0 0 0
Systemic Lupus Erythematosus 0 0
Tourette syndrome 0 0
Type 1 Diabetes 0 0
Type 2 Diabetes 0 0.1 0
Ulcerative colitis 0 0.1 0
Unhealthy Ageing 0 0

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant or equivalent EU laws. [34.239.170 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [34.239.170 ]